FDAR: Leading Daily Disposable Contact Lens with Built In Moisturizer offers All-Day Eye Comfort

Now, contact lens wearers have something to smile about these days. They can experience all-day comfort everyday with the new Focus DAILIES with Aqua Release™,

Developed by Ciba Vision, the new Focus DAILIES with Aqua Release™, is the first daily disposable contact lens to offer a unique breakthrough – the blink-activated technology with built-in moisturizer.

With each blink, the built-in moisturizer is gradually released from the lens into the tear film to keep your eyes moisturized or lubricated. As such, it relieves your eyes from dryness and providing you all-day comfort.

Considered to be the no.1 disposable contact lens in Europe and the U.S., Focus DAILIES with AQUA RELEASE ™, holds the record of being the only contact lens brand to gain a US FDA approval to claim “All-day comfort” on its packaging.   

Apart from the revolutionary blink-activated technology feature, New Focus DAILIES with Aqua Release™ also contains Visitint™, a handling tint that makes it easier to insert and remove the lens, providing more convenience to the contact lens wearer.

Focus DAILIES with AquaRelease™ is available at all leading optical outlets. Focus DAILIES with Aqua Release™ comes in a box of 30s and packs of 5 pieces.

For more information about the new Focus DAILIES with AquaRelease™, visit www.bettereyesforbetterlife.com.

About CIBA Vision

With worldwide headquarters in Atlanta, CIBA Vision is a global leader in research, development and manufacturing of optical and ophthalmic products and services, including contact lenses and lens care products. CIBA Vision products are available in more than 70 countries.
                                                               
For more information, visit the CIBA Vision website at www.cibavision.com.

CIBA Vision is the eye care unit of Novartis {NYSE:NVS}, a world leader in pharmaceuticals and consumer health. In 2005, the Group’s businesses achieved sales of USD 36.2 billion in R&D. Headquartered in Basel, Switzerland; Novartis Group companies employ approximately 80,000 people and operate in over 140 countries around the world.

For further information, please consult www.novartis.com.